Skip to main content
XERS filings

Corporate insider profile

John Johnson Filing Activity

Latest reported as Corporate insider of Xeris Biopharma Holdings, Inc. (XERS).

Purchase filings
0
Reported companies
2
Net open-market value
-$569,389.75
Latest transaction
Jun 4, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 4, 2026Xeris Biopharma Holdings, Inc. (XERS)Corporate insiderSale15,000$6.09$91,422
May 7, 2026Axogen, Inc. (AXGN)Corporate insiderSale11,050$43.26$477,968